Ethical Implications of the Fecal Microbiota Transplantation: Disclosure of a False-Positive HIV Test | Zendy

Caitlyn Hollingshead | Zendy; Jacob Ciricillo | Zendy; Joel Kammeyer | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Ethical Implications of the Fecal Microbiota Transplantation: Disclosure of a False-Positive HIV Test

Author(s) -

Caitlyn Hollingshead,

Jacob Ciricillo,

Joel Kammeyer

Publication year - 2021

Publication title -

case reports in infectious diseases

Language(s) - English

Resource type - Journals

eISSN - 2090-6625

pISSN - 2090-6633

DOI - 10.1155/2021/6696542

Subject(s) - fecal bacteriotherapy , human immunodeficiency virus (hiv) , medicine , transplantation , donation , serology , clostridioides , feces , intensive care medicine , immunology , clostridium difficile , antibody , biology , microbiology and biotechnology , antibiotics , economics , economic growth

Fecal microbiota transplantation (FMT) has gained popularity as an effective therapeutic option for Clostridioides difficile infection (CDI). Since its FDA recognition as a treatment modality for recurrent CDI in 2013, screening protocols for FMT donor stool have been in flux. However, extensive health questionnaires, in combination with serological and stool assays, have become mainstays in the donor screening process, although ethical implications are yet to be thoroughly considered. Herein, we present the case of a family member found to have a false-positive HIV test during the donor screening process and discuss potential ethical ramifications associated with FMT stool donation.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research